We present a candidate Reference Method for determiningthe concentration of serumcreatinine. The methodis basedon HPLC combinedwithenzymaticdetermination. Creatinine plus '4[C]creatinineis extracted by cationexchangechromatography, subjectedto reversed-phase HPLC, and finally quantifiedenzymatically.Enzymatic measurementensures no interferencefrom co-eluting compounds, which has been a problem for some reported HPLC assays relying on ultraviolet detection. The average corrected recovery was 100.1% (SEM = 1.1%; n = 15). The accuracy was verified by assaying five sera with target values determined by isotope dilutionmassspectrometry. The total interassay CV was s2.5%. We applied the method to study the specificity of HPLC-ultraviolet detection, using 72 plasma samples from hospitalized patients; no interference was noted. Thus, HPLC-ultraviolet detection appears to be specific, provided that sample cleanup is based on cation-exchange chromatography. Our diode-array detector studies of peak homogeneity supported this conclusion. Still, combined HPLCenzymaticdetermination ensureseven greateraccuracy, rankingclose to that by isotopedilutionmass spectrometry.
serum samples and assaying (3, (5) (6) (7) , others have noted that serum extracts from uremic patients may contain unknown ultraviolet-absorbing substances that could constitute a problem (8-11). Potential interference in HPLC assays with ultraviolet detection can be circumvented by introducing a more selective detection principle, e.g., enzymatic determination.
Here, we present an HPLC method in which the creatinine fraction is collected and quantified enzymatically.
We demonstrate that the method is without bias, indicating its status as a candidate Reference Method for creatinine. Further, we used this method to systematically evaluate the specificity of HPLC with ultraviolet detection.
Among the numerous HPLC methods published, we selected that of Lim et al. (12) as a basis for part of our method. The sample pretreatment involves cation-exchange chromatography, and the liquid-chromatography is carried out isocratically on a C18 column. We supplemented the method by adding 1-[14CJcreatiine as an internal standard for correction of recovery (13). The enzymatic step is based on the creatinine amidohydrolase (creatininase; see below) and p-aminophenazone system described by Fossati et al. (14) , in a more recent version (2). To optimize calibration, we studied the precision profile and carried out a weighted regression analysis to estimate the calibration function.
MaterIals and Methods Apparatus
A Model 1090 M liquid chromatograph (HewlettPackard Co., Palo Alto, CA) equipped with an ultraviolet diode-array detector and a Foxy fraction collector was used. The column (300 x 4 mm) was packed with Nucleosil C18 (5-pm particles) from Mackerey-Nagel, Dlren, F.R.G. For the absorbance measurements, we used a Pye Umcam (Cambridge, U.K.) SP 1750 spectrephotometer. Radioactive creatinine was measured with a Model 2000 CA liquid scintillation spectrometer (Packard Instrument Co., Downers Grove, IL). The lyephilization apparatus was from Heto Lab Equipment A/S, Birkerod, Denmark. Creatinine calibration solutions were prepared with Class A volumetric pipettes.
Reagents
Aqueous [20] [21] [22] [23] [24] [25] #{176}C. Then we diluted the samples with 10 mL of adsorption buffer (per liter, 40 mmol of citric acid and 20 mmol of Na2HPO4, pH adjusted to 3.00). We filled the plastic extraction columns with 300 mg of resin dissolved in 2 mL of 2.5 mol/L NaOH reagent. We washed the columns with 2 mL of H20, followed by 4 mL of adsorption buffer. The sample dilutions were then poured carefully onto the columns. Having washed the columns twice with 4 mL of H20, we eluted the creatinine with eluting buffer (2 mL added three times), 0.15 molIL ammonium acetate. The eluate was lyophilized.
HPLC. We dissolved the eluates in 500 pL of H20, of which duplicate 100-pL aliquots were injected onto the column. The chromatography was performed with a mobile phase of 0.01 mol/L ammonium acetate and methanol (98/2, by vol) at a flow rate of 1 mLlmin. The retention time of creatinine was determined by monitoring absorbance at 236 nm, and the fraction collector was adjusted accordingly. The creatinine fraction collected was lyophilized. The diode-array detector also recorded the whole ultraviolet spectrum across the creatinine peak for evaluation of peak homogeneity. Chromatograms of an aqueous solution of creatiine and of plasma samples with creatinine concentrations within the reference range and at an increased concentration are displayed in Figure 1 .
Enzymatic determination and measurement of radio-
activity.
The creatinine fractions were dissolved in 1000 pL of H20, of which 500 pLwas transferred 4-aminophenazone chuione dye + HBr + 21120
We redissolved the aliquots in 1000 L of modified Creatinine-PAP reagent solution containing the listed enzymes and cofactors. The modification consisted of a doubling of the Ths' HC1 buffer strength from 0.15 to 0.30 mol/L. To further ensure an appropriate pH (9.0) for the enzymatic reactions, we added 60 of 0.01 mol/L NaOH per milliliter of mobile phase transferred for the enzymatic measurement.
The tubes were incubated at room temperature for 20 mm, and the absorbance of the chinone dye was read at 510 nm. In line with the duplicate runs of calibrators/samples, we measured two reagent blank solutions for each series of samples. The coefficient of variation of the blank measurements was 0.9% (n = 15 duplicate measurements). The difference (hi) between sample and the average blank absorbance was recorded.
Cakulation of results. A linear calibration curve was estimated from a set of seven aqueous calibrators with concentrations (xj) 25, 50, 100, 200, 400, 600, and 1000 pmol/L. The response y, is the net absorbance (hi) corrected for recovery. If we denote the fractional recovery of the isotope as g, then y, is equal to (hgj) or (4h/g), depending on whether 400 or 100 pL was transferred for enzymatic measurement.
In conjunction with the HPLC purification of the isotope, we determined the molar activity, expressed as counts/mm per mole. Accordingly, a correction for the amount of added isotope (-1.5 nmol per 2000 1zL of sample or calibrator) could be made. A linear calibration function was estimated by a weighted least-squares regression procedure (17) (see Appendix).
Results

Evaluation of the HPLC-Enzymatic Procedure
Calibration curve. The average calibration points for 10 analytical series are shown in Figure 2 , together with an estimated regression line. As is apparent from the precision profile (Figure 3) , the SD of the response increases largely in proportion to the concentration when the latter exceeds 100 mol/L, but tends to ap- For the example given, with a ratio of about 10 between the maximum and minimum SD of the response, the weighted approach is about twice as precise as the unweighted regression procedure commonly used (Appendix) .
Linearity of the average calibration curve was confirmed by a variance ratio test (F = 1.12; P >0.3; v1 = 63, v.2 = 5) (17) . We reanalyzed serum samples with concentrations >1000 zmol/L by using 500 instead of 2000 ML of serum.
Accuracy. The recovery of the added isotope in the creatinine fraction by HPLC averaged 83.0% (SD = 4.0%, n = 62). When creatinine was added to serum samples in amounts from 25 to 1000 p.mobL and analyzed by the HPLC-enzymatic procedure, in which extraction losses are taken into account by the isotope, the average recovery was 100.1% (SEM = 1.1%; n = 15). The accuracy of the method (Table 1) was further validated by analyzing the five sera with target values known from ID-MS measurements (15,16). We observed a good agreement between the results by both methods. The deviations from the means of the HPLC-enzymatic measurements from the target values ranged from -2.8% to +1.0%.
Precision. The total interassay CV was estimated to be s2.5% for plasma pools prepared from patients' samples (Table 2 ). An intra-assay CV of 1.5% was recorded for 15 patients' samples analyzed in duplicate in the same series, i.e., true duplicates carried through the whole procedure. Although the HPLC-enzymatic procedure has relatively many steps, the imprecision was kept low by using a tracer as an internal standard and by optimizing the conditions for the enzymatic step. The tracer added corresponded to iO counts/mn, of which about one-tenth was finally counted, i.e., about io counts/mm. A counting time of 10 mm yields i0 counts, so that the CV due to random variation of isotope decay is only (V'i#{246}/10) 100% = 0.3%. When the enzymatic procedure is applied directly to 50 p.L of serum, the relative imprecision is at a minimum at creatinine concentrations >300 moJ/L, corresponding to 15 nmol in the test tube (2). Starting with extraction of 2 mL of serum, of which either 4/50 or 1/50 (depending on the creatinine concentration) is finally measured enzymatically, we obtain 15 nmol in the test tube for creatinine concentrations >100 pmol/L in serum. Additionally, because creatinine is separated from creatine by the HPLC step (Figure 4) , it is not necessary to correct for the creatine content, as is done for serum samples measured directly. This also improves the precision of the assay when applied to HPLC fractions. Finally, the optimized weighted-estimation procedure for the calibration function increases precision.
Detection limit. We used as the lower limit of detection 3 SD for measurements of a low-concentration sample. Assuming that the analytical SD is approximately constant at concentrations <50 moI/L, as is the SD of the detector response (Figure 3) . The limit of detection is thus 3 x 0.88 cmol/L = 2.6 moI/L. Of more interest is the lower limit of quantification, defined as 10-fold the analytical SD, i.e., 8.8 1zniol/L. At this concentration, the CV is 10%.
Interference.
Potential interferants to the HPLC enzymatic procedure are primarily the endogenous and exogenous compounds known to disturb the set of enzymatic reactions we used (2). To interfere, a compound must be extracted and eluted in the same fraction as creatinine on the HPLC column. Ascorbate and bilirubins, both known to inhibit the peroxidase step, are not extracted from serum, as confirmed by analyzing extracts of serum from icteric patients or enriched with ascorbate, 500 moJ/L (the bilirubins were assayed by a diazo method and ascorbate by HPLC). Measurements of the creatinine concentrations of these sera showed interference <0.2%.
Creatine and sarcosine are intermediates of the enzymatic reactions and increase the results for creatinine. Creatine is extracted (about 50%) with creatinine, but elutes before creatinine (Figure 4) . which has a quinone structure (2), interferes with the detection step but is not extracted. Its interference was <0.2%, as judged from measurements of a pool enriched with 500 pmoI/L of calcium dobesilate.
Comparison of HPLC-Enzymatic and HPLC-IJV Measurements
To evaluate systematically whether interference with HPLC-ultraviolet detection of creatinine in patients' samples is a problem, as suggested by some authors (9-11), we analyzed a series of samples by both ultraviolet and enzymatic detection methods. The samples originated from five hospitalized patients whose creatinine values were within the reference interval (44-133 tmol/L) and from 67 patients with renal diseases and increased concentrations, most of whom were undergoing hemodialysis.
The HPLC-ultraviolet results were obtained from an extra assay with an injection volume of only 25 1zL, which is more optimal for ultraviolet detection. The relation between the response (the HPLC peak area at 236 nm divided by the fractional recovery of the isotope) and the concentration was linear to at least 1000 mio1/L (F = 1.05; P >0.3; u = 49; u = 5) ( Figure 5) . Again, the calibration line was estimated by weighted least-squares regression analysis. Denoting the results by HPLC-enzymatic analysis as e and the HPLC-UV results as u, we plotted percent paired differences {[u, -e]/[(e, + u)/2J} x 100% against the average result [(e, + u)/2], as shown in Figure 6 (18) . We evaluated percent (relative) differences because both measurements are subject to proportional random errors. The average of the percent differences, -0.73%, was only slightly different from zero (P <0.02), showing that there is at most a negligible systematic difference between the measurements. The presence of co-eluting ultraviolet-absorbing compounds in a plasma extract would be termed a positive outlier of the relative differences. In Figure 6 , only three observations are located slightly beyond the limits ±2 SD from 0; two are below the lower limit, and one exceeds the upper limit. Of 72 observations, we would expect about three observations beyond the ±2 SD limits, simply from random variation. Thus, we consider that no cases of ultraviolet interference were disclosed for this series of samples, which should be representative in a clinical context. A supplementary way to study the problem of ultraviolet interference is with the diode-array detector. The peak homogeneity is evaluated by a comparison of the spectra recorded up-and down-slope on the peak. A correlation coefficient between the spectra of 0.95 is regarded as a sign of homogeneity (19) . The average for the spectra in our method was r = 0.995 (range 0.950-1.000). Thus, this investigation supported the conclusion of no ultraviolet interference.
Discussion
Generally, ID-MS is considered the most accurate and matrix-independent principle of analysis for low-molecular-mass compounds in clinical chemistry (20) Clin Chem uremic patients (8-10). Cation-exchange chromatography is a more selective cleanup procedure, but interference is still possible and can be excluded only by a systematic evaluation. Commonly, suspected interferants are added to serum samples to study whether the measured creatinine concentration is affected (3-7,22) . However, that type of study discloses interference only from well-characterized endogenous and exogenous compounds, but does not preclude interference from drug metabolites and unknown metabolic products that might accumulate in plasma of patients with renal disease. A better way to study specificity is to assess whether the supposed creatinine peak disappears after treatment with an enzyme that converts creatinine to some other compound. Because interfering compounds may be present in serum of relatively few patients, a reasonably large number of serum samples should be studied to exclude interferences in general. So far, only a few samples have been subjected to enzymatic treatment (8, 22). Further, the presence of a small residual peak after enzymatic treatment may leave the question unsettled about whether the enzymatic breakdown was completed or whether another compound was present. We consider the comparison between the HPLC-ultraviolet and HPLC-enzymatic measurements of a reasonable number of patients' samples as a better way to study the problem. Another possibility would be to compare measurements by HPLC-ultraviolet detection and ID-MS, which so far has been done for only a few plasma pools (3, 24) . The comparison performed here suggests that HPLC-ultraviolet detection, given cationexchange cleanup of plasma samples, is a specific measurement principle, and that the somewhat laborious HPLC-enzymatic combination is not necessary. The latter, however, is very specific, and its accuracy should rank very close to that of ID-MS. A compromise might be to use HPLC-ultraviolet detection, then check peak homogeneity with a diode-array detector, and reserve the HPLC-enzymatic combination for samples with signs of peak impurity.
Quite recently, a cation-exchange HPLC method combined with an unselective sample pretreatment procedure has been proposed as a Reference Method for serum creatinine determination (3). This combination is expected to provide the same degree of specificity as cation-exchange chromatography for sample cleanup combined with a reversed-phase HPLC system. The accuracy of the method seems good, as judged from comparison with ID-MS measurements on four serum pools. The precision, however, was only moderate, with interassay CVs ranging from 3% to 11%. This may be due to the lack of an internal standard in the measurement procedure. The principle in the weighted procedure is to assign more influence to absorbance readings at relatively low concentrations, where the random variation is smallest (Figure 3 ). Computer simulations show that for a calibration model with a ratio of 10 between the largest and smallest SD of the response, the variance of the slope is 50% smaller for the weighted than for the unweighted procedure.
